Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
AbstractBackground: Patients with locally advanced rectal cancer are treated with preoperative chemoradiotherapy followed by surgical resection. Despite similar clinical parameters (uT2-3, uN+) and standard therapy, patients’ prognoses differ widely. A possible prediction of prognosis through microRNAs as biomarkers out of treatment-naïve biopsies would allow individualized therapy options. Methods: Microarray analysis of 45 microdissected preoperative biopsies from patients with rectal cancer was performed to identify potential microRNAs to predict overall survival, disease-free survival, cancer-specific survival, distant-metastasis-free survival, tumor regression grade, or nodal stage. Quantitative real-time polymerase chain reaction (qPCR) was performed on an independent set of 147 rectal cancer patients to validate relevant miRNAs. Results: In the microarray screen, 14 microRNAs were significantly correlated to overall survival. Five microRNAs were included from previous work. Finally, 19 miRNAs were evaluated by qPCR. miR-515-5p, miR-573, miR-579 and miR-802 demonstrated significant correlation with overall survival and cancer-specific survival (p < 0.05). miR-573 was also significantly correlated with the tumor regression grade after preoperative chemoradiotherapy. miR-133b showed a significant correlation with distant-metastasis-free survival. miR-146b expression levels showed a significant correlation with nodal stage. Conclusion: Specific microRNAs can be used as biomarkers to predict prognosis of patients with rectal cancer and possibly stratify patients’ therapy if validated in a prospective study. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 915 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Azizian, A.; Epping, I.; Kramer, F.; Jo, P.; Bernhardt, M.; Kitz, J.; Salinas, G.; Wolff, H.A.; Grade, M.; Beißbarth, T.; Ghadimi, B.M.; Gaedcke, J. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer. Int. J. Mol. Sci. 2016, 17, 568.
Azizian A, Epping I, Kramer F, Jo P, Bernhardt M, Kitz J, Salinas G, Wolff HA, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer. International Journal of Molecular Sciences. 2016; 17(4):568.Chicago/Turabian Style
Azizian, Azadeh; Epping, Ingo; Kramer, Frank; Jo, Peter; Bernhardt, Markus; Kitz, Julia; Salinas, Gabriela; Wolff, Hendrik A.; Grade, Marian; Beißbarth, Tim; Ghadimi, B. M.; Gaedcke, Jochen. 2016. "Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer." Int. J. Mol. Sci. 17, no. 4: 568.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.